We are live on ! Find out more
COCHW icon

Envoy Medical Warrant
COCHW

62 hedge funds and large institutions have $2.34M invested in Envoy Medical Warrant in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

3% more funds holding

Funds holding: 6062 (+2)

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

19% less capital invested

Capital invested by funds: $2.9M → $2.34M (-$561K)

Holders
62
Holders Change
+2
Holders Change %
+3.33%
% of All Funds
0.99%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
7
Reduced
8
Closed
6
Calls
$6.24M
Puts
Net Calls
+$6.24M
Net Calls Change
-$24K

COCHW Hedge Fund Activity: Q1 2023 in Review

62 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical Warrant (COCHW) for Q1 2023, worth a combined $2.34M — down 19% from $2.9M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new COCHW positions and 6 closed out — a net gain of 2 holders — while 7 added to existing stakes and 8 trimmed.

The largest buyer was Bracebridge Capital LLC, opening a new position worth an estimated $14.7K. The largest seller was Mangrove Partners, exiting entirely with an estimated $112K sold.

  • 62 institutional investors held Envoy Medical Warrant (COCHW) as of Q1 2023, up from 60 in Q4 2022.
  • Funds reported $2.34M of Envoy Medical Warrant stock for Q1 2023, down 19% quarter-over-quarter.
  • 8 funds opened new Envoy Medical Warrant positions in Q1 2023 and 6 closed out, a net change of +2 holders.
  • The largest Envoy Medical Warrant buyer in Q1 2023 was Bracebridge Capital LLC, an estimated $14.7K added.
  • The largest Envoy Medical Warrant seller in Q1 2023 was Mangrove Partners, an estimated $112K sold.

Based on aggregated 13F filings for Q1 2023.